Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
 - Shares are not adjusted for stock split.
 
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
 - Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date  | Reported DateTime  | Company | Symbol | Insider Relationship  | Shares Traded  | Average Price  | Total Amount  | Shares Owned  | Filing | 
| 2025-08-18 Purchase  | 2025-08-20 4:02 pm  | ALX ONCOLOGY HOLDINGS INC | ALXO | Shantharam Harish Chief Financial Officer  | 75,000 | $0.7787 | $58,402 | 75,000 (Direct)  | View | 
| 2024-03-22 Sale  | 2024-03-22 5:03 pm  | CymaBay Therapeutics Inc. | CBAY | Shantharam Harish Chief Financial Officer  | 20,125 | $0 | $0 | 0 (Direct)  | View | 
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date  | Reported DateTime  | Exercisable Expiration  | Company | Symnbol | Insider Relationship  | Shares Traded  | Conversion Price  | Shares Owned  | Filing | 
| 2025-10-14 Option Award  | 2025-10-16 4:01 pm  | N/A 2035-10-14  | ALX ONCOLOGY HOLDINGS INC | ALXO | Shantharam Harish Chief Financial Officer  | 198,750 | $0 | 198,750 (Direct)  | View | 
| 2025-04-11 Option Award  | 2025-04-15 4:16 pm  | N/A 2035-04-11  | ALX ONCOLOGY HOLDINGS INC | ALXO | Shantharam Harish Chief Financial Officer  | 125,000 | $0 | 125,000 (Direct)  | View | 
| 2025-01-21 Option Award  | 2025-01-23 6:19 pm  | N/A 2035-01-20  | ALX ONCOLOGY HOLDINGS INC | ALXO | Shantharam Harish Chief Financial Officer  | 600,000 | $0 | 600,000 (Direct)  | View | 
| 2024-01-24 Option Award  | 2024-01-26 6:33 pm  | N/A 2034-01-23  | CymaBay Therapeutics Inc. | CBAY | Shantharam Harish Chief Financial Officer  | 94,875 | $0 | 94,875 (Direct)  | View | 
| 2023-05-22 Option Award  | 2023-05-22 5:13 pm  | N/A 2033-05-21  | CymaBay Therapeutics Inc. | CBAY | Shantharam Harish Chief Financial Officer  | 360,000 | $0 | 360,000 (Direct)  | View |